مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

348
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

120
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

IMMUNOPHENOTYPING OF LEUKEMIA IN CHILDREN, GORGAN, IRAN

Pages

  115-120

Abstract

 Background: LEUKEMIA is one of the most common tumors in CHILDren and it is divided up into two main groups; acute and chronic LEUKEMIA. The acute LEUKEMIA is more prevalent than chronic in CHILDren. Generally acute type is included acute lymphoid LEUKEMIA (ALL) and acute myeloid LEUKEMIA (AML). In this study, patients with LEUKEMIA who were admitted in Talghani hospital of Gorgan were examined for immune markers.Materials and Methods: Forty one patients (34 persons with ALL and 7 persons with AML) were examined. Bone marrow aspiration samples were obtained in tubes containing EDTA and were sent to pathology center of Baghiatallah hospital, Tehran. IMMUNOPHENOTYPING was conducted by Flow cytometry and results were recorded in profiles of patients.Results: The mean age of ALL and AML patients was 5.64±3.43 and 7.45±5.68 years respectively. It was determined that ALL risk in males is 1.086 times more than females. Mann-Whitney test did not show significant difference between mean age of AML and ALL groups (p=0.5). Highest markers in ALL were CD19 (90.2%), CD10 (84.36%), I3 (HLA-DR) (70.58%), and in AML CD45 (81.8%), I3 (HLA-DR) (63.64%) and CD34 (54.5%).Conclusion: The prevalence of markers in ALL and AML patients is different, and some of them are common. These results could be used for differentiation of ALM from ALL. Further study was recommended on bigger sample-size to achieve a definite conclusion.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    MIRBEHBAHANI, N.B., RASHIDBAGHAN, A., NODEHI, H., JAHAZI, A., BEHNAMPOUR, N., JEIHOUNIAN, M., & PAYAB, Z.. (2011). IMMUNOPHENOTYPING OF LEUKEMIA IN CHILDREN, GORGAN, IRAN. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1(4), 115-120. SID. https://sid.ir/paper/320580/en

    Vancouver: Copy

    MIRBEHBAHANI N.B., RASHIDBAGHAN A., NODEHI H., JAHAZI A., BEHNAMPOUR N., JEIHOUNIAN M., PAYAB Z.. IMMUNOPHENOTYPING OF LEUKEMIA IN CHILDREN, GORGAN, IRAN. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY[Internet]. 2011;1(4):115-120. Available from: https://sid.ir/paper/320580/en

    IEEE: Copy

    N.B. MIRBEHBAHANI, A. RASHIDBAGHAN, H. NODEHI, A. JAHAZI, N. BEHNAMPOUR, M. JEIHOUNIAN, and Z. PAYAB, “IMMUNOPHENOTYPING OF LEUKEMIA IN CHILDREN, GORGAN, IRAN,” IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, vol. 1, no. 4, pp. 115–120, 2011, [Online]. Available: https://sid.ir/paper/320580/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button